anlotinib +TQB2450 + Oxaliplatin+S-1
IMMUNOVA
Phase 2 small_molecule active
Quick answer
anlotinib +TQB2450 + Oxaliplatin+S-1 for Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active